Barclays Rates RXO buy, $28 Price Target

Barclays maintains its buy rating for RXO, Inc. with a $28 price target, a 1.49% upside from the current price.

By EarningsIQ Research Desk · Published Jun 27, 2026, 3:03 AM EDT · Updated Jul 1, 2026, 8:01 AM EDT

Reviewed by automated data checks against the source data. How we make and check alerts

Barclays rated RXO, Inc. ($RXO) "buy" with a $28 price target on June 26, 2026.

Since the rating, $RXO is down 1.9% after 1 week, down 11.1% after 1 month and up 5.5% to date (from the $27.12 close on Jun 26, 2026).

RXO RXO, Inc.

$28.60 +122.74% year to date

Daily close · Oct 16, 2026

Key Points

Barclays reiterated its buy rating on RXO, Inc. (NYSE:RXO) with a price target of $28 on June 26, 2026.
Barclays's $28 price target implies 1.49% upside from RXO, Inc.'s ($RXO) current $27.59 share price.
RXO shares traded at approximately $26.90, with a market cap of about $4.47 billion and a forward P/E ratio of 54.1.
Insiders, including CEO Andrew Wilkerson, have been active in trading RXO shares, and analysts maintain varied ratings.

Get $RXO trade alerts by text

We text you when insiders, Congress or big funds trade $RXO. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated RXO, Inc. alert may contain errors. Disclosures

Barclays has reiterated its buy rating for RXO, Inc. (NYSE:RXO), setting a price target of $28. This update came from analyst Brandon Oglenski on June 26, 2026. Shares of RXO traded around $26.90 on Saturday.

Analyst rating track record

Barclays vs. the S&P 500

YTD return +21.86% hypothetical

All-time return +38.96% S&P 500 +37.98%

vs. S&P 500 +0.98% ahead of the index

Hypothetical returns from Barclays's disclosed trades, not real profit or advice. How we model this.

Other Institutional Activity in RXO, Inc.

Several institutional investors have made moves in RXO, Inc. ORBIS Allan Gray Ltd increased its holdings by 1,720,219 shares, bringing its total to 36,397,974 shares valued at about $532.1 million. MFN Partners Management, LP added 532,276 shares, ending with 28,109,942 shares worth approximately $411 million. BlackRock, Inc. also boosted its stake by 267,801 shares, now holding 24,165,879 shares valued at $353.3 million. Finepoint Capital LP grew its position by 684,829 shares to 10,073,618 shares, valued at $147.3 million. Vanguard Portfolio Management LLC and Vanguard Capital Management LLC both opened new positions, with share counts of 9,034,799 and 7,370,484, respectively.

RXO, Inc. Stock Up 36.2%

On Saturday, RXO, Inc. shares traded near $26.90. The company holds a market capitalization of about $4.47 billion and a forward P/E ratio of 54.1. RXO's beta is 1.968, indicating higher volatility compared to the market. The stock's 52-week range spans from $10.43 to $29.86, with a 50-day moving average of $23.13 and a 200-day average of $16.99. RXO has a current ratio of 1.274 and a quick ratio of 1.18, with a debt-to-equity ratio of 46.32.

12-month forecast

$RXO price target

RXO, Inc. daily closes and this analyst's $28 target. Not advice.

Recent Earnings

RXO, Inc. posted revenue of approximately $5.73 billion, though it experienced a slight revenue decline of 0.6%. The company recorded a net margin of -1.83% and a return on equity of -6.78%. RXO's next earnings report is expected on August 6, 2026.

Insider Buying and Selling at RXO, Inc.

CEO Andrew Wilkerson has been active with RXO stock, making multiple transactions. On May 15, 2026, he both bought and sold 168,943 shares. Earlier, on May 2, 2026, Wilkerson sold 40,370 shares at an average price of $19.59. Additionally, Chief Accounting Officer Daniel Morris purchased 13,377 shares on May 15, 2026.

Analysts Set New Price Targets

Barclays maintained its buy rating for RXO, Inc. with a $28 target on June 26, 2026. Stifel upgraded the stock to a buy with a $22 target on May 15, 2026. UBS and Citigroup both maintained hold ratings with $22 and $24 targets, respectively, on May 8, 2026. Truist Securities also maintained a buy rating with a $26 target. The consensus among analysts is a hold, with an average price target of $22.07 based on 15 opinions.

About RXO, Inc.

RXO, Inc. operates in the trucking industry, offering truckload freight brokering services across the United States, Canada, Mexico, Asia, and Europe. The company provides asset-light managed transportation and last-mile services, along with freight forwarding, ocean and air transportation, and customs brokerage. Headquartered in Charlotte, North Carolina, RXO was incorporated in 2022 and is led by CEO Drew M. Wilkerson. The company employs approximately 6,906 people.

Bottom Line

Barclays' reiteration of a buy rating for RXO, Inc. reflects continued confidence in the company's prospects, with a price target of $28. Investors follow these ratings closely as they can influence market perceptions and stock performance. It's important to remember that analyst ratings are based on past data and market conditions, and they may not predict future outcomes.